Chartwell Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-12,803
| Closed | -$1.16M | – | 414 |
|
|
2017
Q2 | $1.16M | Buy |
12,803
+325
| +3% | +$29.5K | 0.04% | 344 |
|
|
2017
Q1 | $1.1M | Sell |
12,478
-71,882
| -85% | -$6.31M | 0.04% | 340 |
|
|
2016
Q4 | $6.99M | Sell |
84,360
-535,265
| -86% | -$44.3M | 0.24% | 151 |
|
|
2016
Q3 | $57.3M | Buy |
+619,625
| New | +$57.3M | 1.02% | 20 |
|
|
2016
Q2 | – | Sell |
-146,547
| Closed | -$12.1M | – | 402 |
|
|
2016
Q1 | $12.1M | Sell |
146,547
-15,978
| -10% | -$1.32M | 0.23% | 120 |
|
|
2015
Q4 | $17M | Sell |
162,525
-127,745
| -44% | -$13.4M | 0.35% | 80 |
|
|
2015
Q3 | $30.6M | Buy |
290,270
+55,570
| +24% | +$5.85M | 0.66% | 38 |
|
|
2015
Q2 | $32.1M | Sell |
234,700
-148,775
| -39% | -$20.3M | 0.63% | 45 |
|
|
2015
Q1 | $47.8M | Buy |
383,475
+258,685
| +207% | +$32.2M | 0.93% | 21 |
|
|
2014
Q4 | $11.3M | Sell |
124,790
-126,380
| -50% | -$11.4M | 0.24% | 180 |
|
|
2014
Q3 | $18.1M | Sell |
251,170
-1,950
| -0.8% | -$141K | 0.41% | 74 |
|
|
2014
Q2 | $15.7M | Buy |
253,120
+32,500
| +15% | +$2.02M | 0.33% | 126 |
|
|
2014
Q1 | $15M | Buy |
220,620
+36,100
| +20% | +$2.46M | 0.31% | 137 |
|
|
2013
Q4 | $13M | Buy |
184,520
+2,795
| +2% | +$197K | 0.27% | 163 |
|
|
2013
Q3 | $13.1M | Sell |
181,725
-53,900
| -23% | -$3.89M | 0.3% | 150 |
|
|
2013
Q2 | $13.1M | Buy |
+235,625
| New | +$13.1M | 0.33% | 122 |
|